Published • loading... • Updated
GLP-1 drugs linked to fewer nerve complications than DPP-4 inhibitors in
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
BIOENGINEER.ORGReposted by 
Scienmag: Latest Science and Health News
Scienmag: Latest Science and Health NewsGLP-1 drugs linked to fewer nerve complications than DPP-4 inhibitors in
GLP-1 receptor agonists, the blockbuster class of drugs behind medications such as semaglutide and liraglutide, have become famous for reshaping blood sugar control and body weight in type 2 diabetes. Now a new study suggests they may also change the fate of one of diabetes’ most feared complications: the diabetic foot. Researchers analyzing the medical […]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
